Premium
Symbiotec Pharmalab Pvt. Ltd has attracted interest from a new set of global private equity investors, as majority owner Actis Advisers Pvt. Ltd looks to sell its stake in the maker of bulk drugs, two persons briefed on the development told VCCircle.Actis was previously in talks with two private equity ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
